Since IL7 and IL15 both contribute to increased T-cell survival and Th1 induction, our findings could represent a B-cell and monocyte-driven pro-inflammatory response in the peripheral immune compartment of MS patients. This evidence concerns the gene IL15 and myeloid sarcoma.